Expression of plasma microRNA-145-5p and its correlation with clinical features in patients with refractory epilepsy
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 154, 21-25
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81701266, 81671283)
- Medical Health Sci-tech Program of ZheJiang Province (2017RC004)
This publication has 24 references indexed in Scilit:
- Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factorsClinical Neurology and Neurosurgery, 2016
- Factors predictive of late remission in a cohort of Chinese patients with newly diagnosed epilepsySeizure: European Journal of Epilepsy, 2016
- Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomasJournal of Neuroinflammation, 2015
- miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2NeuroMolecular Medicine, 2014
- MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial CellsMolecular Pharmacology, 2013
- Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transportAdvanced Drug Delivery Reviews, 2012
- Mechanisms of epileptogenesis and potential treatment targetsThe Lancet Neurology, 2011
- Course and outcome of childhood epilepsy: A 15‐year follow‐up of the Dutch Study of Epilepsy in ChildhoodEpilepsia, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- Expression and Cellular Distribution of Multidrug Resistance–related Proteins in the Hippocampus of Patients with Mesial Temporal Lobe EpilepsyEpilepsia, 2004